翰宇药业
(300199)
| 流通市值：110.60亿 | | | 总市值：138.32亿 |
| 流通股本：7.06亿 | | | 总股本：8.83亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 137,761,180.37 | 73,829,807.63 | 45,298,653.04 | 344,006,609.99 |
| 应收票据及应收账款 | 101,053,348.1 | 128,224,859.33 | 171,038,772.55 | 143,047,612.69 |
| 其中：应收票据 | 2,167,402.65 | 325,800 | 117,260 | 698,968 |
| 应收账款 | 98,885,945.45 | 127,899,059.33 | 170,921,512.55 | 142,348,644.69 |
| 应收款项融资 | 1,493,414.8 | 528,344.8 | 2,075,910.44 | 2,376,670.65 |
| 预付款项 | 9,018,493.96 | 12,117,410.55 | 20,067,291.15 | 11,876,279.7 |
| 其他应收款合计 | 9,305,934.67 | 9,820,808.62 | 11,173,053.35 | 6,717,744.28 |
| 存货 | 250,198,043.27 | 200,478,416.84 | 151,522,049.48 | 152,593,626.36 |
| 其他流动资产 | 39,201,605.53 | 27,438,532.35 | 19,891,104.22 | 23,019,795.89 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 548,032,020.7 | 452,438,180.12 | 421,066,834.23 | 683,638,339.56 |
| 非流动资产: | | | | |
| 长期股权投资 | 3,466,920.56 | 3,728,852.02 | - | - |
| 其他权益工具投资 | 5,768,123.54 | 5,768,123.54 | 5,768,123.54 | 5,768,123.54 |
| 其他非流动金融资产 | 18,921,599.13 | 19,244,006.72 | 19,158,139.37 | 19,124,926.53 |
| 投资性房地产 | 243,612,791.07 | 245,385,892.83 | 245,001,153.09 | 244,970,715.04 |
| 固定资产 | 1,600,944,832.29 | 1,619,293,951.2 | 1,638,983,593.87 | 1,666,597,810.74 |
| 在建工程 | 107,153,608.46 | 82,171,845.64 | 74,146,357.01 | 67,316,586.05 |
| 使用权资产 | 181,207.88 | 405,041.5 | - | 208,059.2 |
| 无形资产 | 308,379,158.3 | 297,894,030.05 | 216,938,913.56 | 222,495,040.26 |
| 开发支出 | 117,003,995.11 | 130,867,765.61 | 209,709,069.13 | 207,093,091.42 |
| 长期待摊费用 | 14,296,168.19 | 13,627,041.28 | 11,129,775.64 | 10,717,753.43 |
| 递延所得税资产 | 42,662,674.26 | 41,778,332.87 | 39,379,097.93 | 39,548,011.46 |
| 其他非流动资产 | 106,695,665.05 | 117,199,760.05 | 109,399,196.49 | 109,715,254.33 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,569,086,743.84 | 2,577,364,643.31 | 2,569,613,419.63 | 2,593,555,372 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 3,117,118,764.54 | 3,029,802,823.43 | 2,990,680,253.86 | 3,277,193,711.56 |
| 流动负债: | | | | |
| 短期借款 | 546,176,215.4 | 435,080,606.25 | 324,828,102.77 | 617,205,179.35 |
| 应付票据及应付账款 | 167,786,904.91 | 140,753,553.83 | 112,602,045.13 | 108,495,716.35 |
| 应付账款 | 167,786,904.91 | 140,753,553.83 | 112,602,045.13 | 108,495,716.35 |
| 预收款项 | 4,410,098.63 | 4,305,034.41 | 4,985,664.9 | 4,044,759.42 |
| 合同负债 | 70,861,771.52 | 53,774,506.62 | 55,672,539.76 | 51,890,528.15 |
| 应付职工薪酬 | 28,230,789.71 | 27,730,921.6 | 23,142,163.44 | 23,768,773.51 |
| 应交税费 | 7,310,749.78 | 8,058,946.12 | 8,476,554.08 | 5,555,665.09 |
| 其他应付款合计 | 112,195,581.27 | 102,478,714.81 | 174,451,483.72 | 152,788,787.04 |
| 一年内到期的非流动负债 | 340,315,876.03 | 294,268,929.97 | 317,419,311.97 | 453,389,912.42 |
| 其他流动负债 | 8,357,131.75 | 6,530,108.74 | 6,666,012.32 | 6,299,651.33 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,285,645,119 | 1,072,981,322.35 | 1,028,243,878.09 | 1,423,438,972.66 |
| 非流动负债: | | | | |
| 长期借款 | 664,011,254.8 | 754,695,799.8 | 762,449,095.8 | 641,846,539.8 |
| 应付债券 | 297,488,427.01 | 297,227,884 | 296,967,340.99 | 296,706,797.98 |
| 长期应付款 | 3,500,000 | 3,500,000 | 3,500,000 | 3,500,000 |
| 预计负债 | 22,288,491.85 | 22,288,491.85 | 22,288,491.85 | 22,288,491.85 |
| 递延收益 | 108,757,350.43 | 94,118,270.63 | 97,970,384.9 | 101,188,707.63 |
| 递延所得税负债 | 5,012,925.78 | 5,012,925.78 | 5,012,925.78 | 5,012,925.78 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 1,101,058,449.87 | 1,176,843,372.06 | 1,188,188,239.32 | 1,070,543,463.04 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,386,703,568.87 | 2,249,824,694.41 | 2,216,432,117.41 | 2,493,982,435.7 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 883,241,336 | 883,241,336 | 883,241,336 | 883,241,336 |
| 资本公积 | 1,447,129,451.52 | 1,468,434,185.72 | 1,466,794,685.7 | 1,463,482,861.34 |
| 其他综合收益 | 38,555,937.94 | 39,913,920.65 | 39,508,061.7 | 39,269,852.08 |
| 盈余公积 | 56,688,751.56 | 56,688,751.56 | 56,688,751.56 | 56,688,751.56 |
| 未分配利润 | -1,718,684,780.59 | -1,694,237,933.95 | -1,698,287,116.42 | -1,683,879,140.68 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 706,930,696.43 | 754,040,259.98 | 747,945,718.54 | 758,803,660.3 |
| 少数股东权益 | 23,484,499.24 | 25,937,869.04 | 26,302,417.91 | 24,407,615.56 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 730,415,195.67 | 779,978,129.02 | 774,248,136.45 | 783,211,275.86 |
| 负债和股东权益合计 | 3,117,118,764.54 | 3,029,802,823.43 | 2,990,680,253.86 | 3,277,193,711.56 |
| 公告日期 | 2024-10-30 | 2024-08-24 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |